Heart Failure: Connecting R & D with the patient experience
We delivered 7 versions of our live simulation experiences globally to research and development teams within a large pharma company.
The what and why…
A large pharma company approached us with a challenge to help support their R & D and clinical teams during the development phase of their heart failure drugs.
The client was looking specifically at building a greater connect between clinical research teams and the end patient. We worked closely with the client and created 7 versions of our immersive simulation experience that delivered exactly on their requirements and with great success to over 100 people. They were so pleased with the results the programme was rolled out globally throughout 2020.
- Initial programme delivered to Europe, Asia and USA teams
- Rolled out globally through 2020
- Year long availability of the simulation
The results…
“This was an amazing experience. It’s easy to learn about conditions and how to treat them but putting yourself in the shoes of a patient really uncovers the many other difficulties individuals face on a daily basis.”
This highly immersive simulation programme proved to be a true eye opener for many of the participants involved. The incredible effect the experience had helped increase patient focus around the impact of heart failure and encouraged clinical staff to think even more empathically about heart failure in new creative ways.
It was encouraging to us and true testament to the power of this unique programme that our client was so pleased with the initial results that they quickly signed off on a global roll out to all their R & D teams.